Mecka | $60,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
Plot | $10,000,000 | (Jun 3, 2026)
Certified by Founder
Lodge
OverT Bio
start up
United States
- New York, NY
- 07/05/2024
- Seed
- $16,000,000
Finding new genes to power transformative cell therapies.
- Industry Biotechnology Research
- Website https://www.overt.bio/home
- LinkedIn https://www.linkedin.com/company/overt-bio/
Related People
Mat LegutCo Founder
United States -
New York, New York
My scientific interests focus on developing T-cell immunotherapies for hard-to-treat solid tumors.
KOSMOS | $5,000,000 | (Jun 3, 2026)
Phosio Corporation | $4,000,000 | (Jun 3, 2026)
StratusGrid | $3,000,000 | (Jun 3, 2026)
Subtle Medical | $33,000,000 | (Jun 3, 2026)
Tavo Biotherapeutics | $17,000,000 | (Jun 3, 2026)
Contraline | $92,500,000 | (Jun 3, 2026)
Gigaton | $26,000,000 | (Jun 3, 2026)
Westmag | $11,000,000 | (Jun 3, 2026)
Inherent | $50,000,000 | (Jun 2, 2026)